Regulus Therapeutics Inc (NASDAQ:RGLS)

0.738
Delayed Data
As of May 25
 +0.016 / +2.22%
Today’s Change
0.63
Today|||52-Week Range
1.60
-29.04%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.72
Today’s open0.73
Day’s range0.72 - 0.74
Volume100,453
Average volume (3 months)470,365
Market cap$74.8M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+38.06%
Earnings growth (this year)+41.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.97%
P/E ratioNM
Price/Sales1,086.67
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...+0.03+0.50%
GTXIGTX Inc+0.36+1.85%
ZFGNZafgen Inc-0.38-5.78%
MEIPMEI Pharma Inc-0.03-0.95%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$72.0K
Annual profit (last year)-$71.9M
Net profit margin-99,868.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts